palbociclib
Blood test could predict treatment effectiveness months earlier in breast cancer
March 6, 2018Manufacturing and Production, Research and Development Cancer, ICR, Institute of Cancer Research, Royal Marsden NHS Foundation Trust, breast cancer, palbociclib, pharma
A team of scientists at The Institute of Cancer Research in London and The Royal Marsden NHS Foundation Trust have …
AstraZeneca’s Faslodex gets US FDA nod in combination treatment for breast cancer
March 8, 2016Manufacturing and Production, Research and Development AstraZeneca, Faslodex, US FDA, palbociclib
UK drug-maker AstraZeneca said the US Food and Drug Administration (FDA) has approved a new indication expanding the use of …
Pfizer breast cancer trial stopped following promising results
April 15, 2015Sales and Marketing ASCO, FDA, Pfizer, ibrance, palbociclib
Regulators have stopped a Phase III clinical trial of Pfizer’s Ibrance early after it demonstrated improved survival in women with …
Pfizer gets early approval for breast cancer drug
February 4, 2015Sales and Marketing FDA, Pfizer, Xalkori (crizotinib), axitinib, bosulif, bosutinib, femara, ibrance, inlyta, letrozole, palbociclib
The FDA has shown Pfizer’s breast cancer drug Ibrance an early green light to treat patients who are at the …
Pfizer breast cancer pill gets FDA nod
October 14, 2014Research and Development, Sales and Marketing FDA, Femera, LEE011, Pfizer, bemaciclib, breast cancer, palbociclib
Pfizer’s experimental breast cancer drug palbociclib has been accepted and granted a priority review by the US Food and Drug …
Pfizer to submit breast cancer drug
May 18, 2014Research and Development, Sales and Marketing Pfizer, breast cancer, femara, palbociclib
Pfizer, currently in the middle of trying to acquire AstraZeneca for $106 billion, says it will soon submit its new …
Pfizer breast cancer drug combo aces trial
April 7, 2014Femera, Pfizer, breast cancer, oncology, palbociclib
Pfizer breast cancer drug shows promise
February 4, 2014Research and Development, Sales and Marketing Cancer, Pfizer, breast, femara, letrozole, palbociclib
Pfizer’s experimental breast cancer drug palbociclib has successfully extended progression-free survival in a Phase II trial. The pill was administered …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
